Top Markets
Coin of the day
Guardion Health Sciences, Inc. Guardion Health Sciences, Inc.

Guardion Health Sciences, Inc.

GHSI
Rangering i aksjer #35279
Guardion Health Sciences, Inc. (GHSI), along with its various affiliates,... Guardion Health Sciences, Inc. (GHSI), along with its various affiliates, functions as a specialized healthcare enterprise operating within the United States. The company's operations are divided into two primary segments: Medical Foods and Nutraceuticals, and Medical Devices. Under its Medical Foods division, Guardion Health Sciences offers Lumega-Z, a therapeutic food designed to replenish and restore the eye's macular protective pigment. It also provides GlaucoCetin, a specialized medical food formulated to support and safeguard the mitochondrial function of optic nerve cells, and to improve ophthalmic artery blood flow in patients afflicted with glaucoma. In the Medical Devices sector, the company supplies MapcatSF, a device used to precisely measure macular pigment optical density. It also markets the CSV-1000, which conducts self-calibrated tests to ensure accurate luminance and contrast levels, and the CSV-2000, a digital system for standardized contrast sensitivity testing. Moreover, Guardion Health Sciences develops, manufactures, and distributes equipment and accessories for standardized vision screening under the VectorVision name, utilized by vision care professionals in clinical research, real-world diagnostic evaluations, and occupational vision assessments. Furthermore, the company is actively developing ImmuneSF, a new nutraceutical blend, and manages a comprehensive collection of nutritional supplement products marketed under its NutriGuard brand. Its medical food items are distributed directly to consumers via its online store, guardionhealth.com. Guardion Health Sciences, Inc. was established in 2009 and is headquartered in San Diego, California.
Aksjekurs
$3.25
Sist synkronisert: 2026-03-09
Markedsverdi
$4.17M
Endring (1 dag)
0.00%
Endring (1 år)
0.93%
Land
US
Handel Guardion Health Sciences, Inc. (GHSI)

Kategori

P/E-forhold for Guardion Health Sciences, Inc. (GHSI)
P/E-forhold per 2026 TTM: 0
Ifølge Guardion Health Sciences, Inc. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Guardion Health Sciences, Inc. fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.